OBJECTIVE: Mobile Health (mHealth) approaches can support the rehabilitation of individuals with psychiatric conditions. In the current article, we describe the development of a smartphone illness self-management system for people with schizophrenia. METHODS: The research was conducted with consumers and practitioners at a community-based rehabilitation agency. Stage 1: 904 individuals with schizophrenia or schizoaffective disorder completed a survey reporting on their current use of mobile devices and interest in mHealth services. Eight practitioners completed a survey examining their attitudes and expectations from an mHealth intervention, and identified needs and potential obstacles. Stage 2: A multidisciplinary team incorporated consumer and practitioner input and employed design principles for the development of e-resources for people with schizophrenia to produce an mHealth intervention. Stage 3: 12 consumers participated in laboratory usability sessions. They performed tasks involved in operating the new system, and provided "think aloud" commentary and post-session usability ratings. RESULTS: 570 (63%) of survey respondents reported owning a mobile device and many expressed interest in receiving mHealth services. Most practitioners believed that consumers could learn to use and would benefit from an mHealth intervention. In response, we developed a smartphone system that targets medication adherence, mood regulation, sleep, social functioning, and coping with symptoms. Usability testing revealed several design vulnerabilities, and the system was adapted to address consumer needs and preferences accordingly. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: Through a comprehensive development process, we produced an mHealth illness self-management intervention that is likely to be used successfully, and is ready for deployment and systemic evaluation in real-world conditions. PsycINFO Database Record (c) 2013 APA, all rights reserved.
OBJECTIVE: Mobile Health (mHealth) approaches can support the rehabilitation of individuals with psychiatric conditions. In the current article, we describe the development of a smartphone illness self-management system for people with schizophrenia. METHODS: The research was conducted with consumers and practitioners at a community-based rehabilitation agency. Stage 1: 904 individuals with schizophrenia or schizoaffective disorder completed a survey reporting on their current use of mobile devices and interest in mHealth services. Eight practitioners completed a survey examining their attitudes and expectations from an mHealth intervention, and identified needs and potential obstacles. Stage 2: A multidisciplinary team incorporated consumer and practitioner input and employed design principles for the development of e-resources for people with schizophrenia to produce an mHealth intervention. Stage 3: 12 consumers participated in laboratory usability sessions. They performed tasks involved in operating the new system, and provided "think aloud" commentary and post-session usability ratings. RESULTS: 570 (63%) of survey respondents reported owning a mobile device and many expressed interest in receiving mHealth services. Most practitioners believed that consumers could learn to use and would benefit from an mHealth intervention. In response, we developed a smartphone system that targets medication adherence, mood regulation, sleep, social functioning, and coping with symptoms. Usability testing revealed several design vulnerabilities, and the system was adapted to address consumer needs and preferences accordingly. CONCLUSIONS AND IMPLICATIONS FOR PRACTICE: Through a comprehensive development process, we produced an mHealth illness self-management intervention that is likely to be used successfully, and is ready for deployment and systemic evaluation in real-world conditions. PsycINFO Database Record (c) 2013 APA, all rights reserved.
Authors: Mario Álvarez-Jiménez; John F Gleeson; Sarah Bendall; R Lederman; G Wadley; E Killackey; Patrick D McGorry Journal: Psychiatr Clin North Am Date: 2012-09
Authors: Virginia Harrison; Judith Proudfoot; Pang Ping Wee; Gordon Parker; Dusan Hadzi Pavlovic; Vijaya Manicavasagar Journal: J Ment Health Date: 2011-10-11
Authors: Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller Journal: Schizophr Bull Date: 2009-12-02 Impact factor: 9.306
Authors: Brianna S Fjeldsoe; Yvette D Miller; Jasmine L O'Brien; Alison L Marshall Journal: Int J Behav Nutr Phys Act Date: 2012-12-20 Impact factor: 6.457
Authors: Jasper E Palmier-Claus; John Ainsworth; Matthew Machin; Cristine Barrowclough; Graham Dunn; Emma Barkus; Anne Rogers; Til Wykes; Shitij Kapur; Iain Buchan; Emma Salter; Shôn W Lewis Journal: BMC Psychiatry Date: 2012-10-17 Impact factor: 3.630
Authors: Matthew J Smith; Emily J Ginger; Michael Wright; Katherine Wright; Laura Boteler Humm; Dale Olsen; Morris D Bell; Michael F Fleming Journal: J Nerv Ment Dis Date: 2014-09 Impact factor: 2.254